How do differences in onset, symptoms, and treatment response arise between various mental illnesses despite substantial overlap of genetic risk factors? To address this question, we carried out deep RNA sequencing of human postmortem subgenual anterior cingulate cortex, a key component of limbic circuits linked to mental illness. Samples were obtained from 200 individuals diagnosed with bipolar disorder, schizophrenia, or major depression, and controls. Differential expression analysis in cases versus controls detected modest differences that were similar across disorders, although transcript-level differences were more pronounced. Case-case comparisons revealed greater expression differences between disorders, including many genes and transcripts that were expressed in opposite directions in each diagnostic group, compared to controls. Relative transcript abundances were associated with common genetic variants that accounted for disproportionate fractions of diagnosis-specific heritability. Inherited genetic risk factors shape the brain transcriptome and contribute to diagnostic differences between broad classes of mental illness.
Gene-level AnalysesCase-Control comparisons: To explore case-control differences in gene expression, all 21,000 genes were quantile normalized for library size, gene GC-content and gene length. Differential expression analysis was performed for each diagnosis group versus controls using DESeq2 14 , with covariates for RNA integrity number (RIN), reported race, and sample GC contentthe only measured variables that were significantly associated, after Bonferroni-correction, with one or more principal components of gene expression ( Supplementary Table 3).Sensitivity analyses carried out with surrogate variables for high-dimensional data sets (SVA) 15 and with additional covariates found similar results, but the chosen 3-covariate model produced the smallest genome-wide inflation in test statistics (Supplementary Figure 3). As expected, differential expression between cases and controls was modest. Absolute log2 fold change (FC) differences were ≤0.5 in all diagnostic groups. At FDR <5%, a total of 23, 42, and 7 genes were DE in SCZ, BD and MDD, respectively (Figure 1a). Genes that were DE at FDR<5% in more than 1 diagnostic group are shown in Table 1. Many of the same genes were DE in multiple disorders, with a mean overlap of 42% (Figure 2a.). All DE genes with nominal p<0.05 are shown in Supplementary Tables 4, 5 and 6.Among genes DE within any one diagnostic group, there was a strong positive correlation in FC values across diagnoses (linear regression R 2 0.61 to 0.72) (Figure 3a). When we compared the DE genes detected at FDR<5% in sgACC to those identified in a published study of DLPFC 6 , we found significant overlap for SCZ (hypergeometric p-value=8.0x10 -6 ) and BD (hypergeometric p-value=6.8x10 -5 ) ( Supplementary Table 4 & 5).To confirm these results, the data were normalized, corrected for covariates, and analyzed using analysis of variance (ANOVA). Over 80% of the DE gen...